A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients
Abroad (travel likely)RecruitingPHASE1
Conditions
Diabetic Kidney Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking University First Hospital, Beijing, Beijing Municipality, China
Study leads
Hong Zhang
Principal Investigator
Peking University First Hospital
Ying Gao
Principal Investigator
Peking University First Hospital